Hemealumen TS: Revolutionary Polychromatic Photobiomodulation System
Product Overview
The Hemealumen Polychromatic Device is a cutting-edge, minimally invasive photoluminescence blood treatment system designed to combat auto-immune, viral, bacterial, and fungal diseases. It is also effective for treating similar conditions in pets, including dogs and cats. This advanced device enhances patient outcomes by utilizing light-based therapy to stimulate the body’s natural healing processes.
Clinical Excellence Redefined
Immediate Impact: Complete resolution of dengue/zika in 48 hours. 55/55 malaria cases resolved in 2 days. Zero COVID-19 mortality with 7-day reduced hospital stays.
Proven Safety: Over 80 years of clinical use with >95% success rates across 6,500+ patients. Zero adverse effects reported in 200+ peer-reviewed studies.
Revolutionary Technology: Patented TRIVETTE™ design increases blood exposure time by 600% compared to traditional devices, delivering superior therapeutic outcomes through polychromatic wavelength integration.
How Hemealumen TS Works:
Advanced Polychromatic Precision
Patented
TRIVETTE™ Triple Quartz Tube Design
The revolutionary triple-tube parallel arrangement extends blood exposure time by 600%, ensuring comprehensive pathogen inactivation and optimal cellular activation. This patented design represents the first significant advancement in UVBI technology.
Targeted Pulsed Frequencies
Proprietary frequency modulation similar to Rife technology ensures precise cellular targeting while maximizing therapeutic efficacy across multiple biological systems.
Transform Patient Outcomes
Six-Wavelength Polychromatic System
UVC 253.7nm: Direct DNA/RNA damage to pathogens while preserving host cell integrity
UVA: Enhanced immune cell activation and phagocytic capacity
Blue 450nm: Vasodilation, reduced inflammatory markers, improved blood flow
Green 525nm: Blood rheology optimization, decreased viscosity, enhanced electrophoretic mobility
Amber 590nm: Nitric oxide production, mood enhancement, anti-depression effects
Red 675nm: Primary enzyme support (SOD, Catalase), mitochondrial energy optimization
Clinical Evidence:
Transforming Medical Outcomes
Viral Infections - Breakthrough Results:
Hepatitis C: 44.9% peak viral load reduction in FDA Phase II trial (p=0.0048)
COVID-19: 7-day hospital stay reduction with zero mortality rates
Dengue/Zika: Complete resolution within 48 hours (Costa Rica clinical study)
Long COVID: Significant symptom improvement with declining D-dimer levels
Bacterial Infections - Superior Efficacy:
Tuberculosis: 100% disease-free rate vs. 58.8% in control groups
Sepsis: Historical 95%+ success rate across 6,500+ patients
MRSA/Antibiotic-Resistant Strains: No reported resistance development
Pneumonia: 24-76 hour symptom resolution
Autoimmune and Inflammatory Conditions
Rheumatoid Arthritis: 70-92% improvement rates
Asthma: Significant improvement in steroid-resistant cases
Multiple Sclerosis: 14/26 patients showed good clinical response
Psoriasis: Marked improvement in concurrent treatment cases
Cardiovascular Applications
Peripheral Arterial Disease: 3x improvement in walking distance
Thrombophlebitis: 24-48 hour clot resolution
Enhanced oxygen utilization and delivery
Significant blood viscosity reduction
Engineering Excellence
Technical Specifications
Advanced LED Array System
60 High-Power LEDs: Delivering precise wavelength targeting
Wavelength Range: 253.7nm UVC to 675nm Red light
Power Output: 60 watts across multiple visible wavelengths
Treatment Duration: Optimized exposure protocols for maximum efficacy
User Interface and Controls
Touchscreen Interface: Intuitive operation for clinical staff
Pre-programmed Protocols: Evidence-based treatment parameters
Real-time Monitoring: Continuous treatment parameter display
Safety Interlocks: Multiple fail-safe mechanisms
Patented TRIVETTE™ Cuvette Design
Touchscreen Interface: Intuitive operation for clinical staff
Pre-programmed Protocols: Evidence-based treatment parameters
Real-time Monitoring: Continuous treatment parameter display
Safety Interlocks: Multiple fail-safe mechanisms
AS SEEN AT
Unique Therapeutic Mechanisms
Beyond Traditional UVBI
Nagalase Dismantling Technology
Exclusive capability to dismantle nagalase protein produced by cancer cells, viruses, and bacteria - a breakthrough mechanism unavailable in traditional UVBI devices.
Enhanced NAD+/NADH Activity
Optimized cellular energy production through specific wavelength targeting, supporting mitochondrial function and cellular regeneration.
Biofilm Elimination
Advanced capability to combat resistant biofilm formations that protect pathogens from conventional treatments.
COMPANY
CUSTOMER CARE
LEGAL
FOLLOW US
Copyright 2025. ALD Devices. All Rights Reserved.